dc.contributor.author |
Du Preez, WB
|
|
dc.contributor.author |
Richter, PW
|
|
dc.contributor.author |
Hope, D
|
|
dc.contributor.author |
Kotze, CP
|
|
dc.date.accessioned |
2007-08-03T07:00:01Z |
|
dc.date.available |
2007-08-03T07:00:01Z |
|
dc.date.issued |
2006-07 |
|
dc.identifier.citation |
Du Preez, WB, et al. 2006. Eyeborn – restored quality of life for the visually impaired. All Africa technology diffusion conference, Boksburg, South Africa, 2006, 10p. |
en |
dc.identifier.uri |
http://hdl.handle.net/10204/1078
|
|
dc.description.abstract |
Eyeborn is an innovative hydroxyapatite orbital implant used to replace the eyeball of a patient who has lost an eye. A prosthetic eye cap is fitted in front of the Eyeborn implant, restoring the patient’s appearance and improving his quality of life. The product was developed with funding from the South African Innovation Fund. This paper shares some of the lessons learnt during the commercialisation of the product and the technology transfer to a South African small enterprise, Cerdak (Pty) Ltd. Aspects, such as the inputs of medical experts, clinical trials, development of the commercialisation model, identification of a marketing company and a manufacturer, accessing funding and contracting, are discussed. The technology transfer process included compliance with international quality system standards and the acquisition of the CE Mark for the product. Timing of the market launch and subsequent complications regarding provision in market demand during the technology transfer phase posed special challenges. In this regard the role of the marketing company, VisiCare (Pty) Ltd, is discussed. |
en |
dc.language.iso |
en |
en |
dc.subject |
Eyeborn |
en |
dc.subject |
Technology transfer |
en |
dc.subject |
Hydroxyapatite orbital implant |
en |
dc.subject |
Eyeborn implants |
en |
dc.title |
Eyeborn – restored quality of life for the visually impaired |
en |
dc.type |
Conference Presentation |
en |
dc.identifier.apacitation |
Du Preez, W., Richter, P., Hope, D., & Kotze, C. (2006). Eyeborn – restored quality of life for the visually impaired. http://hdl.handle.net/10204/1078 |
en_ZA |
dc.identifier.chicagocitation |
Du Preez, WB, PW Richter, D Hope, and CP Kotze. "Eyeborn – restored quality of life for the visually impaired." (2006): http://hdl.handle.net/10204/1078 |
en_ZA |
dc.identifier.vancouvercitation |
Du Preez W, Richter P, Hope D, Kotze C, Eyeborn – restored quality of life for the visually impaired; 2006. http://hdl.handle.net/10204/1078 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Du Preez, WB
AU - Richter, PW
AU - Hope, D
AU - Kotze, CP
AB - Eyeborn is an innovative hydroxyapatite orbital implant used to replace the eyeball of a patient who has lost an eye. A prosthetic eye cap is fitted in front of the Eyeborn implant, restoring the patient’s appearance and improving his quality of life. The product was developed with funding from the South African Innovation Fund. This paper shares some of the lessons learnt during the commercialisation of the product and the technology transfer to a South African small enterprise, Cerdak (Pty) Ltd. Aspects, such as the inputs of medical experts, clinical trials, development of the commercialisation model, identification of a marketing company and a manufacturer, accessing funding and contracting, are discussed. The technology transfer process included compliance with international quality system standards and the acquisition of the CE Mark for the product. Timing of the market launch and subsequent complications regarding provision in market demand during the technology transfer phase posed special challenges. In this regard the role of the marketing company, VisiCare (Pty) Ltd, is discussed.
DA - 2006-07
DB - ResearchSpace
DP - CSIR
KW - Eyeborn
KW - Technology transfer
KW - Hydroxyapatite orbital implant
KW - Eyeborn implants
LK - https://researchspace.csir.co.za
PY - 2006
T1 - Eyeborn – restored quality of life for the visually impaired
TI - Eyeborn – restored quality of life for the visually impaired
UR - http://hdl.handle.net/10204/1078
ER -
|
en_ZA |